scholarly journals Antihypertensive use and risk of intradialytic hypotension in hospitalized end-stage renal disease patients

2018 ◽  
Vol 1 (2) ◽  
Author(s):  
Andrew Nishimoto ◽  
◽  
Benjamin T Duhart ◽  
Robert B Canada ◽  
David Shoop ◽  
...  
2017 ◽  
Vol 45 (1-3) ◽  
pp. 61-70 ◽  
Author(s):  
Gabriele Donati ◽  
Mauro Ursino ◽  
Alessandra Spazzoli ◽  
Nicolò Natali ◽  
Roberto Schillaci ◽  
...  

Background: Sodium prescription in patients with intradialytic hypotension remains a challenge for the attending nephrologist, as it increases dialysate conductivity in hypotension-prone patients, thereby adding to dietary sodium levels. Methods: New sodium prescription strategies are now available, including the use of a mathematical model to compute the sodium mass to be removed during dialysis as a physiological controller. Results: This review describes the sodium load of patients with end-stage renal disease on chronic hemodialysis (HD) and discusses 2 strategies to remove excess sodium in patients prone to intradialytic hypotension, namely, Profiled HD and the hemodiafiltration Aequilibrium System. Conclusion: The Profiled HD and Aequilibrium System trial both proved effective in counteracting intradialytic hypotension.


2021 ◽  
pp. 12-15
Author(s):  
A. O. Nykonenko ◽  
S. R. Vildanov

Introduction. Nowadays hemodialysis is the most widespread way of treatment concerning the end-stage renal disease. The variant of choice as for permanent vascular access for hemodialysis is arteriovenous fistula. An actual problem is the deterioration of the patency of arteriovenous fistula. According to the research, most patients do not know about the risks associated with intradialytic hypotension. Under these conditions, research with determining the level of critical intradialytic hypotension is particularly relevant. Purpose of the work is to study and evaluate intradialytic hypotension as a risk factor for thrombosis of arteriovenous fistulas. Materials and methods. 60 patients were examined with end-stage renal disease, receiving of hemodialysis. Among these patients a thrombosis of arteriovenous fistula appeared in the long term (7.5 (3.0–17.6) months) after the surgery. The average age of patients was (54.1 ± 11.8) years; there were 30 (50%) men, 30 (50%) women. Results. According to the results of our study, 38 (63 %) patients had hypotension at the end of the hemodialysis session. Conclusions. Blood hypotension is one of the main predictors of thrombosis of arteriovenous fistula in the late postoperative period. A decrease in systolic blood pressure on 35.0 (25.0–50.0) mm Hg to 100.0 (90.0–110.0) mm Hg is critical for the patency of arteriovenous fistula. Adequate control and correction of blood pressure (in particular, during a hemodialysis session) can prevent thrombosis of arteriovenous fistula.


Sign in / Sign up

Export Citation Format

Share Document